The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent Nos. 10,017,810 and 10,450,597. Both patents concern DNA preparation...more
8/21/2025
/ Appeals ,
Appellate Courts ,
Biotechnology ,
CAFC ,
Claim Construction ,
Doctrine of Equivalents ,
Intellectual Property Litigation ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patents